Loading…
Based on limited metadata, this warning letter addresses OriGen Biomedical, Inc., a medical device manufacturer, for unspecified regulatory violations. Without access to the full letter text or specific subject line, the exact nature of the compliance issues cannot be determined from the available information. The FDA issued this warning on December 20, 2018, indicating that the company's medical device operations did not meet applicable regulatory requirements. To understand the specific violations and required corrective actions, the complete warning letter would need to be reviewed.